Cargando…

Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey

This study investigated the frequency of antimicrobial non-susceptibility (defined as the frequency of isolates with minimum inhibitory concentrations above the CLSI susceptible clinical breakpoint) among E. coli and Salmonella spp. isolated from healthy Australian finisher pigs. E. coli (n = 201) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kidsley, Amanda K., Abraham, Sam, Bell, Jan M., O'Dea, Mark, Laird, Tanya J., Jordan, David, Mitchell, Pat, McDevitt, Christopher A., Trott, Darren J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047343/
https://www.ncbi.nlm.nih.gov/pubmed/30038598
http://dx.doi.org/10.3389/fmicb.2018.01207
_version_ 1783339936597934080
author Kidsley, Amanda K.
Abraham, Sam
Bell, Jan M.
O'Dea, Mark
Laird, Tanya J.
Jordan, David
Mitchell, Pat
McDevitt, Christopher A.
Trott, Darren J.
author_facet Kidsley, Amanda K.
Abraham, Sam
Bell, Jan M.
O'Dea, Mark
Laird, Tanya J.
Jordan, David
Mitchell, Pat
McDevitt, Christopher A.
Trott, Darren J.
author_sort Kidsley, Amanda K.
collection PubMed
description This study investigated the frequency of antimicrobial non-susceptibility (defined as the frequency of isolates with minimum inhibitory concentrations above the CLSI susceptible clinical breakpoint) among E. coli and Salmonella spp. isolated from healthy Australian finisher pigs. E. coli (n = 201) and Salmonella spp. (n = 69) were isolated from cecal contents of slaughter-age pigs, originating from 19 farms distributed throughout Australia during July-December 2015. Isolates underwent minimum inhibitory concentration (MIC) susceptibility testing to 11 antimicrobials. The highest frequencies of non-susceptibility among respective isolates of E. coli and Salmonella spp. were to ampicillin (60.2 and 20.3%), tetracycline (68.2 and 26.1%), chloramphenicol (47.8 and 7.3%), and trimethoprim/sulfamethoxazole (33.8 and 11.6%). Four E. coli isolates had MICs above the wild-type epidemiological cut-off value for ciprofloxacin, with two isolates from the same farm classified as clinically resistant (MICs of > 4 μg/ml), a noteworthy finding given that fluoroquinolones (FQs) are not legally available for use in Australian food-producing animals. Three of these four E. coli isolates belonged to the sequence type (ST) 10, which has been isolated from both humans and production animals, whilst one isolate belonged to a new ST (7573) and possessed qnrS1. This study shows that non-susceptibility to first line antimicrobials is common among E. coli and Salmonella spp. isolates from healthy slaughter age pigs in Australia. However, very low levels of non-susceptibility to critically important antimicrobials (CIAs), namely third generation cephalosporins and fluoroquinolones were observed. Nevertheless, the isolation of two ciprofloxacin-resistant E. coli isolates from Australian pigs demonstrates that even in the absence of local antimicrobial selection pressure, fluoroquinolone-resistant E. coli clonal lineages may enter livestock production facilities despite strict biosecurity.
format Online
Article
Text
id pubmed-6047343
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60473432018-07-23 Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey Kidsley, Amanda K. Abraham, Sam Bell, Jan M. O'Dea, Mark Laird, Tanya J. Jordan, David Mitchell, Pat McDevitt, Christopher A. Trott, Darren J. Front Microbiol Microbiology This study investigated the frequency of antimicrobial non-susceptibility (defined as the frequency of isolates with minimum inhibitory concentrations above the CLSI susceptible clinical breakpoint) among E. coli and Salmonella spp. isolated from healthy Australian finisher pigs. E. coli (n = 201) and Salmonella spp. (n = 69) were isolated from cecal contents of slaughter-age pigs, originating from 19 farms distributed throughout Australia during July-December 2015. Isolates underwent minimum inhibitory concentration (MIC) susceptibility testing to 11 antimicrobials. The highest frequencies of non-susceptibility among respective isolates of E. coli and Salmonella spp. were to ampicillin (60.2 and 20.3%), tetracycline (68.2 and 26.1%), chloramphenicol (47.8 and 7.3%), and trimethoprim/sulfamethoxazole (33.8 and 11.6%). Four E. coli isolates had MICs above the wild-type epidemiological cut-off value for ciprofloxacin, with two isolates from the same farm classified as clinically resistant (MICs of > 4 μg/ml), a noteworthy finding given that fluoroquinolones (FQs) are not legally available for use in Australian food-producing animals. Three of these four E. coli isolates belonged to the sequence type (ST) 10, which has been isolated from both humans and production animals, whilst one isolate belonged to a new ST (7573) and possessed qnrS1. This study shows that non-susceptibility to first line antimicrobials is common among E. coli and Salmonella spp. isolates from healthy slaughter age pigs in Australia. However, very low levels of non-susceptibility to critically important antimicrobials (CIAs), namely third generation cephalosporins and fluoroquinolones were observed. Nevertheless, the isolation of two ciprofloxacin-resistant E. coli isolates from Australian pigs demonstrates that even in the absence of local antimicrobial selection pressure, fluoroquinolone-resistant E. coli clonal lineages may enter livestock production facilities despite strict biosecurity. Frontiers Media S.A. 2018-07-09 /pmc/articles/PMC6047343/ /pubmed/30038598 http://dx.doi.org/10.3389/fmicb.2018.01207 Text en Copyright © 2018 Kidsley, Abraham, Bell, O'Dea, Laird, Jordan, Mitchell, McDevitt and Trott. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Kidsley, Amanda K.
Abraham, Sam
Bell, Jan M.
O'Dea, Mark
Laird, Tanya J.
Jordan, David
Mitchell, Pat
McDevitt, Christopher A.
Trott, Darren J.
Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey
title Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey
title_full Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey
title_fullStr Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey
title_full_unstemmed Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey
title_short Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey
title_sort antimicrobial susceptibility of escherichia coli and salmonella spp. isolates from healthy pigs in australia: results of a pilot national survey
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047343/
https://www.ncbi.nlm.nih.gov/pubmed/30038598
http://dx.doi.org/10.3389/fmicb.2018.01207
work_keys_str_mv AT kidsleyamandak antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey
AT abrahamsam antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey
AT belljanm antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey
AT odeamark antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey
AT lairdtanyaj antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey
AT jordandavid antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey
AT mitchellpat antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey
AT mcdevittchristophera antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey
AT trottdarrenj antimicrobialsusceptibilityofescherichiacoliandsalmonellasppisolatesfromhealthypigsinaustraliaresultsofapilotnationalsurvey